Goldman Sachs, Morgan Stanley downgrade China stocks

Goldman Sachs economists released an analysis that projected that President-elect Trump's tax cuts and deregulation will ...
Investors have been trading meme stocks and loading up on cryptocurrencies since Donald Trump won the presidential ...
Gold advanced after posting its biggest weekly drop since 2021, as the dollar edged lower and traders weighed the outlook for ...
Goldman Sachs analyst Chris Shibutani maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $137.00. The company’s shares closed last Friday at $99.72.
Goldman Sachs Research predicts a strong year for global economic growth in 2025, forecasting a 2.7% increase in global GDP ...
Wall Street investment banking giant Goldman Sachs holds more than $700 million in spot Bitcoin ETF (exchange-traded fund) ...
The Wall Street giant set out to build a marketing 'army' under its first CMO. Some high-level insiders question whether it's ...
Hedge funds ended the week as net buyers of stocks in U.S. financial and healthcare companies, according to ...